{"id":6,"date":"2023-12-22T13:00:28","date_gmt":"2023-12-22T11:00:28","guid":{"rendered":"https:\/\/www.ipsen.com\/it\/?page_id=6"},"modified":"2025-02-12T19:10:24","modified_gmt":"2025-02-12T17:10:24","slug":"home","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/it\/","title":{"rendered":"Home"},"content":{"rendered":"\t<!-- Hero Carousel Start Here-->\n\t<section class=\"hero-section blue-filter\">\n\t\t<div class=\"hero_fullwidth \"><!-- container class shown if gridlayout choosen -->\n\t\t\t<div id=\"heroCarousel\" class=\"carousel slide herocaro hero-banner-bg-image\" data-bs-ride=\"carousel\" data-enableplaybtn=\"\" data-autoplay= \"1\"  data-autospeed= \"5000\" >\n\t\t\t\t<!-- Slider Indicator-->\n\t\t\t\t<div class=\"carousel-indicators visible\">\n\t\t\t\t<button type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide-to=\"0\" class=\"active\" aria-current=\"true\" aria-label=\"Slide 0\"><\/button><button type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide-to=\"1\" class=\"\" aria-current=\"true\" aria-label=\"Slide 1\"><\/button><button type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide-to=\"2\" class=\"\" aria-current=\"true\" aria-label=\"Slide 2\"><\/button>\t\t\t\t<\/div>\n\t\t\t\t<!-- Items -->\n\t\t\t\t<div class=\"carousel-inner\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t<!-- Hero Banner with carousel HTML -->\n\t\t\t\t\t\t<div class=\"carousel-item active\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"bd-placeholder-img visible\" width=\"100%\" height=\"100%\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2025\/01\/30154537\/Module-1_Carrousel_FTFPS_1920x720pix.jpg\" aria-hidden=\"true\" title=\"Hero Banner\" alt=\"Hero Banner\" \/> \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t<div class=\"container align-left\">\n\t\t\t\t\t\t\t\t<div class=\"carousel-caption\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"visible text-start\">Focus. Together. For patients and society.<\/h2>\n\t\t\t\t\t\t\t\t\t<div class=\"visible text-start\">Lavoriamo in tre aree terapeutiche per generare progresso e innovazione, con un impatto positivo nella vita delle persone e della societ\u00e0.<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"visible text-start\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"btn btn-lg btn-primary\" href=\"https:\/\/www.ipsen.com\/it\/chi-siamo\/\" aria-label=\"Scopri di pi\u00f9 about Focus. Together. For patients and society.\" target=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\tScopri di pi\u00f9\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t<!-- Hero Banner with carousel HTML -->\n\t\t\t\t\t\t<div class=\"carousel-item \">\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"bd-placeholder-img visible\" width=\"100%\" height=\"100%\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2025\/01\/30154641\/Module-1_Carrousel_WOB_1920x720pix.jpg\" aria-hidden=\"true\" title=\"Hero Banner\" alt=\"Hero Banner\" \/> \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t<div class=\"container align-left\">\n\t\t\t\t\t\t\t\t<div class=\"carousel-caption\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"visible text-start\">Ipsen Way of Being<\/h2>\n\t\t\t\t\t\t\t\t\t<div class=\"visible text-start\">La nostra identit\u00e0 si riflette nell&#8217;Ipsen Way of Being, che guida la nostra cultura incentrata sulla collaborazione e l\u2019eccellenza\u00a0per offrire le migliori soluzioni terapeutiche.<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"visible text-start\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"btn btn-lg btn-primary\" href=\"https:\/\/www.ipsen.com\/it\/lavorare-in-ipsen\/\" aria-label=\"Scopri di pi\u00f9 about Ipsen Way of Being\" target=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\tScopri di pi\u00f9\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t<!-- Hero Banner with carousel HTML -->\n\t\t\t\t\t\t<div class=\"carousel-item \">\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"bd-placeholder-img visible\" width=\"100%\" height=\"100%\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2025\/01\/30154753\/Module-1_Carrousel_R-and-D_1920x720pix.jpg\" aria-hidden=\"true\" title=\"Hero Banner\" alt=\"Hero Banner\" \/> \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t<div class=\"container align-left\">\n\t\t\t\t\t\t\t\t<div class=\"carousel-caption\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"visible text-start\">Guidati dai cambiamenti che possiamo generare nella vita delle persone<\/h2>\n\t\t\t\t\t\t\t\t\t<div class=\"visible text-start\">Siamo concentrati sull&#8217;innovazione medico-scientifica e i nostri team di R&amp;D lavorano allo sviluppo di un portfolio terapeutico efficace e sostenibile, per rispondere ai bisogni di chi affronta malattie complesse.<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"visible text-start\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"btn btn-lg btn-primary\" href=\"https:\/\/www.ipsen.com\/research-and-development\/\" aria-label=\"Scopri di pi\u00f9 about Guidati dai cambiamenti che possiamo generare nella vita delle persone\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\t\t\tScopri di pi\u00f9\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<button class=\"carousel-control-prev visible\" aria-label=\"Previous-slide\" type=\"button\"  title=\"previous\" data-bs-target=\"#heroCarousel\" data-bs-slide=\"prev\">\n\t\t\t\t\t\t<span class=\"carousel-control-prev-icon\" aria-hidden=\"true\"><\/span>\n\t\t\t\t\t<\/button>\n\t\t\t\t\t<button class=\"carousel-control-next visible\" aria-label=\"Diapositiva successiva\" type=\"button\" title=\"next\" type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide=\"next\">\n\t\t\t\t\t\t<span class=\"carousel-control-next-icon\" aria-hidden=\"true\"><\/span>\n\t\t\t\t\t<\/button>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div id=\"carouselButtons\" class=\"visible visible\">\n\t\t\t\t\t\t<button id=\"playButton\" class=\"hidden\" aria-label=\"Diapositiva successiva\" type=\"button\"><\/button>\n\t\t\t\t\t\t<button id=\"pauseButton\" aria-label=\"Diapositiva successiva\" type=\"button\"><\/button>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\t<!-- Hero Carousel End Here-->\n  \n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#DBEAF5;\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <span class=\"dash\"><\/span> \n                        <p class=\"heading-para\">\n                            CHI SIAMO                        <\/p>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h2 class=\"heading-para\">\n                                                    <\/h2>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>Ipsen \u00e8 un&#8217;azienda biofarmaceutica con una presenza globale. Ci impegniamo per migliorare la vita dei pazienti di tutto il mondo, attraverso la ricerca, l&#8217;innovazione e lo sviluppo di farmaci trasformativi in oncologia, nelle neuroscienze e nell&#8217;ambito delle malattie rare.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner \">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row \">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065727\/02_WhatWeDo_DSA01946-1.png\" alt=\"IL NOSTRO IMPEGNO\" title=\"IL NOSTRO IMPEGNO\">\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                                <span class=\"dash\"><\/span>\n                                <p class=\"heading-para\">\n                                    IL NOSTRO IMPEGNO                                <\/p>\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                                                    <\/p>\n                        <p>Perseguiamo con determinazione un grande obiettivo: migliorare la qualit\u00e0 di vita di chi, direttamente e indirettamente, affronta ogni giorno sfide complesse con elevati bisogni medici non ancora soddisfatti. Siamo determinati a sostenere lo sviluppo della nostra pipeline per realizzare appieno il potenziale delle innovazioni medico-scientifiche e renderle disponibili a chi ne ha bisogno.<\/p>\n                            <a \n                            aria-label=\"\"  \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/research-and-development\/\" \n                                target=\"_self\"\n                            > \n                                Scopri di pi\u00f9 \n                            <\/a>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n    <section class=\"slim-card blue-bg left\">\n        <div class=\"container\">\n          <div class=\"slim-card-inner\">\n                         <div class=\"slim-standard-section\">\n    <div class=\"slim-standard-section-inner\">\n        <div class=\"row normal-div\">\n                            <div class=\"column-1 col-xl-3 col-md-12 col-sm-12 with-carousel\">\n                    <div class=\"slim-standard-heading-div\">\n                        <h2 class=\"charcoal-grey visible\">Le ultime notizie<\/h2>\n                        <p class=\"slim-standard-para charcoal-grey visible\"> Scopri le notizie pi\u00f9 recenti del mondo Ipsen<\/p>\n                    <\/div>\n                <\/div>\n            \n            <div class=\"column-2 col-xl-9 col-md-12 col-sm-12\">\n                <!-- slim-standard carousel -->\n                <div class=\"slim-standard-carousel multiple\">\n                    <div class=\"glider-contain\">\n                                                    <div class=\"slim-standard-content-btn\">\n                                <button aria-label=\"Precedente\" class=\"glider-slim-standard-prev disabled\" aria-disabled=\"true\">\n                                    <span><\/span>\n                                <\/button>\n                                <button aria-label=\"Prossimo\" class=\"glider-slim-standard-next\" aria-disabled=\"false\">\n                                    <span><\/span>\n                                <\/button>\n                            <\/div>\n                        \n                        <div class=\"glider-slim-standard\">\n                                                            <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/asco-gu-2025-i-benefici-di-sopravvivenza-precoce-sono-stati-mantenuti-per-piu-di-cinque-anni-con-cabozantinib-in-associazione-a-nivolumab-rispetto-a-sunitinib-nel-carcinoma-a-cellule-renali-avanzato\/\" class=\"slim-standard-tab glider-slide left-0\" data-gslide=\"0 active visible\" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"ASCO GU 2025: I benefici di sopravvivenza precoce sono stati mantenuti per pi\u00f9 di cinque...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"ASCO GU 2025: I benefici di sopravvivenza precoce sono stati mantenuti per pi\u00f9 di cinque...\" title=\"ASCO GU 2025: I benefici di sopravvivenza precoce sono stati mantenuti per pi\u00f9 di cinque...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"ASCO GU 2025: I benefici di sopravvivenza precoce sono stati mantenuti per pi\u00f9 di cinque...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 12 Febbraio 2025 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            ASCO GU 2025: I benefici di sopravvivenza precoce sono stati mantenuti per pi\u00f9 di cinque&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/malattie-colestatiche-rare-ipsen-al-congresso-aasld-2024-presentati-nuovi-dati-nella-colangite-biliare-primitiva-pbc-nella-colestasi-intraepatica-familiare-progressiva-pfic-e-nella-sindrome-di\/\" class=\"slim-standard-tab glider-slide left-1\" data-gslide=\"1  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Malattie colestatiche rare &#8211; Ipsen al Congresso AASLD 2024: presentati nuovi dati nella Colangite Biliare...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Malattie colestatiche rare &#8211; Ipsen al Congresso AASLD 2024: presentati nuovi dati nella Colangite Biliare...\" title=\"Malattie colestatiche rare &#8211; Ipsen al Congresso AASLD 2024: presentati nuovi dati nella Colangite Biliare...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Malattie colestatiche rare &#8211; Ipsen al Congresso AASLD 2024: presentati nuovi dati nella Colangite Biliare...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 19 Novembre 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Malattie colestatiche rare &#8211; Ipsen al Congresso AASLD 2024: presentati nuovi dati nella Colangite Biliare&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/giornata-mondiale-dellictus-45mila-italiani-sviluppano-ogni-anno-disturbi-neurologici-come-la-spasticita-ma-in-pochi-sono-informati-preventivamente-lindagine-di-elma-research-rive\/\" class=\"slim-standard-tab glider-slide left-2\" data-gslide=\"2  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Giornata mondiale dell\u2019ictus: 45mila italiani sviluppano ogni anno disturbi neurologici come la spasticit\u00e0, ma in...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Giornata mondiale dell\u2019ictus: 45mila italiani sviluppano ogni anno disturbi neurologici come la spasticit\u00e0, ma in...\" title=\"Giornata mondiale dell\u2019ictus: 45mila italiani sviluppano ogni anno disturbi neurologici come la spasticit\u00e0, ma in...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Giornata mondiale dell\u2019ictus: 45mila italiani sviluppano ogni anno disturbi neurologici come la spasticit\u00e0, ma in...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 28 Ottobre 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Giornata mondiale dell\u2019ictus: 45mila italiani sviluppano ogni anno disturbi neurologici come la spasticit\u00e0, ma in&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/ipsen-nelle-malattie-colestatiche-rare-approvati-nellunione-europea-elafibranor-per-la-colangite-biliare-primitiva-pbc-e-odevixibat-per-la-sindrome-di-alagille-algs\/\" class=\"slim-standard-tab glider-slide left-3\" data-gslide=\"3  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Ipsen nelle malattie colestatiche rare: approvati nell\u2019Unione Europea elafibranor per la Colangite Biliare Primitiva (PBC)...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Ipsen nelle malattie colestatiche rare: approvati nell\u2019Unione Europea elafibranor per la Colangite Biliare Primitiva (PBC)...\" title=\"Ipsen nelle malattie colestatiche rare: approvati nell\u2019Unione Europea elafibranor per la Colangite Biliare Primitiva (PBC)...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Ipsen nelle malattie colestatiche rare: approvati nell\u2019Unione Europea elafibranor per la Colangite Biliare Primitiva (PBC)...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 25 Settembre 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen nelle malattie colestatiche rare: approvati nell\u2019Unione Europea elafibranor per la Colangite Biliare Primitiva (PBC)&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/esmo-2024-i-risultati-finali-dello-studio-di-fase-iii-cabinet-rafforzano-i-benefici-in-termini-di-efficacia-di-cabozantinib-nei-tumori-neuroendocrini-avanzati\/\" class=\"slim-standard-tab glider-slide left-4\" data-gslide=\"4  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"ESMO 2024: i risultati finali dello studio di Fase III CABINET rafforzano i benefici in...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"ESMO 2024: i risultati finali dello studio di Fase III CABINET rafforzano i benefici in...\" title=\"ESMO 2024: i risultati finali dello studio di Fase III CABINET rafforzano i benefici in...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"ESMO 2024: i risultati finali dello studio di Fase III CABINET rafforzano i benefici in...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 19 Settembre 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            ESMO 2024: i risultati finali dello studio di Fase III CABINET rafforzano i benefici in&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/ipsen-estende-laccordo-di-collaborazione-e-licenza-per-lo-sviluppo-di-cabozantinib-compresse-nei-tumori-neuroendocrini-avanzati-sulla-base-dello-studio-positivo-cabinet-di-fase-iii\/\" class=\"slim-standard-tab glider-slide left-5\" data-gslide=\"5  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Ipsen estende l&#8217;accordo di collaborazione e licenza per lo sviluppo di cabozantinib (compresse) nei tumori...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Ipsen estende l&#8217;accordo di collaborazione e licenza per lo sviluppo di cabozantinib (compresse) nei tumori...\" title=\"Ipsen estende l&#8217;accordo di collaborazione e licenza per lo sviluppo di cabozantinib (compresse) nei tumori...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Ipsen estende l&#8217;accordo di collaborazione e licenza per lo sviluppo di cabozantinib (compresse) nei tumori...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 03 Luglio 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen estende l&#8217;accordo di collaborazione e licenza per lo sviluppo di cabozantinib (compresse) nei tumori&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/world-kidney-cancer-day-oggi-si-celebra-la-giornata-mondiale-di-sensibilizzazione-sul-tumore-del-rene-ideata-dalla-rete-internazionale-di-associazioni-pazienti-ikcc-per-sensibilizzare-la-popolazio\/\" class=\"slim-standard-tab glider-slide left-6\" data-gslide=\"6  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"World Kidney Cancer Day: oggi si celebra la Giornata Mondiale di sensibilizzazione sul tumore del...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"World Kidney Cancer Day: oggi si celebra la Giornata Mondiale di sensibilizzazione sul tumore del...\" title=\"World Kidney Cancer Day: oggi si celebra la Giornata Mondiale di sensibilizzazione sul tumore del...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"World Kidney Cancer Day: oggi si celebra la Giornata Mondiale di sensibilizzazione sul tumore del...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 20 Giugno 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            World Kidney Cancer Day: oggi si celebra la Giornata Mondiale di sensibilizzazione sul tumore del&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/malattie-epatobiliari-rare-ipsen-presenta-al-congresso-easl-i-risultati-sullefficacia-a-lungo-termine-di-elafibranor-e-i-dati-sulla-qualita-di-vita-associata-al-prurito-nelle-persone-con-co\/\" class=\"slim-standard-tab glider-slide left-7\" data-gslide=\"7  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Malattie epatobiliari rare &#8211; Ipsen presenta al Congresso EASL i risultati sull\u2019efficacia a lungo termine...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Malattie epatobiliari rare &#8211; Ipsen presenta al Congresso EASL i risultati sull\u2019efficacia a lungo termine...\" title=\"Malattie epatobiliari rare &#8211; Ipsen presenta al Congresso EASL i risultati sull\u2019efficacia a lungo termine...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Malattie epatobiliari rare &#8211; Ipsen presenta al Congresso EASL i risultati sull\u2019efficacia a lungo termine...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 10 Giugno 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Malattie epatobiliari rare &#8211; Ipsen presenta al Congresso EASL i risultati sull\u2019efficacia a lungo termine&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/ipsen-una-nuova-storia-nelle-malattie-epatiche-rare\/\" class=\"slim-standard-tab glider-slide left-8\" data-gslide=\"8  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Ipsen, una nuova storia nelle malattie epatiche rare\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13125930\/Comunication-Stampa_1082x620.jpg\" aria-label=\"Ipsen, una nuova storia nelle malattie epatiche rare\" title=\"Ipsen, una nuova storia nelle malattie epatiche rare\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Ipsen, una nuova storia nelle malattie epatiche rare\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 29 Febbraio 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen, una nuova storia nelle malattie epatiche rare                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/press-releases\/carcinoma-differenziato-della-tiroide-refrattario-alla-terapia-con-iodio-radioattivo-aifa-approva-la-rimborsabilita-per-la-nuova-indicazione-di-cabozantinib-compresse\/\" class=\"slim-standard-tab glider-slide left-9\" data-gslide=\"9  \" >\n                                    <div class=\"highligth-row\">\n                                        <div aria-label=\"Carcinoma differenziato della tiroide refrattario alla terapia con iodio radioattivo: AIFA approva la rimborsabilit\u00e0 per...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <div>                                                            \n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/02\/13123329\/MicrosoftTeams-image-41.jpg\" aria-label=\"Carcinoma differenziato della tiroide refrattario alla terapia con iodio radioattivo: AIFA approva la rimborsabilit\u00e0 per...\" title=\"Carcinoma differenziato della tiroide refrattario alla terapia con iodio radioattivo: AIFA approva la rimborsabilit\u00e0 per...\" >\n                                                            <\/div>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                        <div  aria-label=\"Carcinoma differenziato della tiroide refrattario alla terapia con iodio radioattivo: AIFA approva la rimborsabilit\u00e0 per...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button tabindex=\"-1\" class=\"btn small-btn grey-bg visible\" style=\"background-color:#5d6265;\"> Comunicato Stampa <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 13 Febbraio 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Carcinoma differenziato della tiroide refrattario alla terapia con iodio radioattivo: AIFA approva la rimborsabilit\u00e0 per&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n\n                                        <\/div>\n                                <\/a>\n                                                <\/div>\n                    <\/div>\n\n                <\/div><!--standard-carousel-over -->\n            <\/div><!--grid-div-over -->\n        <\/div>\n\n        <div class=\"slimcard-btn-sec\">\n                    <\/div>\n\n    <\/div>\n<\/div>\n           <\/div>\n        <\/div>\n    <\/section>\n\n\n<!-- Page Card Start -->\n<section class=\"text-tryo\">\n    <div class=\"container\" id=\"enable_heading_description\" data-alignment=\"Left\" data-enable_heading=\"1\"\n        data-enable_description=\"1\">\n\n                \n                <div class=\"row\">\n            <div class=\"col-lg-3 col-md-12  \">\n                <div class=\"sec-five-text\">\n                                    <h2 class=\"trayo-page-heading visible\">Il nostro impegno<\/h2>\n                                        <p class=\"trayo-page-summary visible\">Siamo impegnati nella ricerca e nello sviluppo di trattamenti innovativi in tre aree terapeutiche complesse e con ampi bisogni medici insoddisfatti: oncologia, neuroscienze e malattie rare.<\/p>\n                <\/div>\n            <\/div>\n            <div class=\"col-lg-9 col-md-12 \">\n                <!-- Slider Start -->\n                                        <div class=\"text_tray_glider\">\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/oncologia\/\"\n                                target=\"_self\">\n                                <div class=\"img-tray img-one\"\n                                    style='background-image:url(\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065730\/04_1_HowWeHelpPeople_ONCOLOGY_Ronny_181204-209-1.jpg\");'>\n                                    <div class=\"tray\">\n                                        <div class=\"tray-inner\"\n                                            style=\"border-left: 5px solid #224a81 ;\">\n                                            <p class=\"tray-heading-para\">Oncologia<\/p>\n                                            <p class=\"tray-para\">Ipsen \u00e8 presente nell&#8217;area dell\u2019oncologia dal 1986 e oggi dispone di un portfolio di farmaci che include trattamenti per tumori neuroendocrini (NET) e tumori del rene, del fegato, della tiroide, della prostata e della mammella.<\/p>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                            <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/malattie-rare\/\"\n                                target=\"_self\">\n                                <div class=\"img-tray img-one\"\n                                    style='background-image:url(\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12203738\/Together-for-Rare-Disease_Savannah_Card-270x200pix.png\");'>\n                                    <div class=\"tray\">\n                                        <div class=\"tray-inner\"\n                                            style=\"border-left: 5px solid #224a81 ;\">\n                                            <p class=\"tray-heading-para\">Malattie Rare<\/p>\n                                            <p class=\"tray-para\">Il 94% delle malattie rare non dispone di soluzioni terapeutiche. Siamo determinati a sviluppare trattamenti per malattie e disturbi estremamente rari, disturbi della crescita, tumori rari, malattie epatiche rare e disturbi neurogenetici rari.<\/p>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                            <\/a>\n                                                        <a href=\"https:\/\/www.ipsen.com\/it\/neurologia\/\"\n                                target=\"_self\">\n                                <div class=\"img-tray img-one\"\n                                    style='background-image:url(\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065732\/04_3_HowWeHelpPeople_NEUROSCIENCE_Diana_ipsen-128-1.jpg\");'>\n                                    <div class=\"tray\">\n                                        <div class=\"tray-inner\"\n                                            style=\"border-left: 5px solid #224a81 ;\">\n                                            <p class=\"tray-heading-para\">Neuroscienze<\/p>\n                                            <p class=\"tray-para\">Con 30 anni di esperienza nell&#8217;ambito delle tossine e delle neuroscienze, Ipsen \u00e8 impegnata nella ricerca per rispondere ai bisogni di bambini e adulti che vivono con malattie neurologiche debilitanti e degenerative.<\/p>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                <\/div>\n                <!-- Slider End -->\n            <\/div>\n        <\/div>\n                    <\/div>\n<\/section>\n\n<!-- Page Card End -->\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065733\/05-01_PATIENTS_Text-and-Photos-Overlapped_181204-324_RONNY.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                                        <div class=\"carousel-item \">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065736\/05-03_PATIENTS_Text-and-Photos-Overlapped_20201011_6792-HD_LIU-GANG.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                                        <div class=\"carousel-item \">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065738\/05-04_PATIENTS_Text-and-Photos-Overlapped_526A1119_STEPHEN.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                                        <div class=\"carousel-item \">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065740\/05-06_PATIENTS_Text-and-Photos-Overlapped_Ipsen-Crewe-Steve-Pointon_079_STEVE.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                                        <div class=\"carousel-item \">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065741\/05-07_PATIENTS_Text-and-Photos-Overlapped_Misha-spastic-cerebral-palsy_237-HD_MISHA.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                                    <div class=\"carousel-indicators\">\n                                                                                            <button type=\"button\" data-bs-target=\"#image-carousel\" data-bs-slide-to=\"0\"\n                                                    class=\"active\" aria-current=\"true\" aria-label=\"Immagine del dispositivo di scorrimento 0\"><\/button>\n                                                                                            <button type=\"button\" data-bs-target=\"#image-carousel\" data-bs-slide-to=\"1\"\n                                                    class=\"active\" aria-current=\"true\" aria-label=\"Immagine del dispositivo di scorrimento 1\"><\/button>\n                                                                                            <button type=\"button\" data-bs-target=\"#image-carousel\" data-bs-slide-to=\"2\"\n                                                    class=\"active\" aria-current=\"true\" aria-label=\"Immagine del dispositivo di scorrimento 2\"><\/button>\n                                                                                            <button type=\"button\" data-bs-target=\"#image-carousel\" data-bs-slide-to=\"3\"\n                                                    class=\"active\" aria-current=\"true\" aria-label=\"Immagine del dispositivo di scorrimento 3\"><\/button>\n                                                                                            <button type=\"button\" data-bs-target=\"#image-carousel\" data-bs-slide-to=\"4\"\n                                                    class=\"active\" aria-current=\"true\" aria-label=\"Immagine del dispositivo di scorrimento 4\"><\/button>\n                                                                                    <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                <div class=\"heading-dash\">\n                                        <span class=\"dash\"><\/span>\n                                        <p class=\"heading-para-right\">\n                                            PAZIENTI                                        <\/p>\n                                    <\/div>\n                                                                                            <h3 class=\"section-head-two\">\n                                        Lavorare insieme ai pazienti, per i pazienti                                     <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        La volont\u00e0 di fare la differenza per migliorare la vita delle persone \u00e8 la forza motrice che guida tutte le nostre decisioni. Crediamo nell\u2019importanza di lavorare insieme ai pazienti, ascoltando i loro bisogni e coinvolgendoli nel nostro percorso.                                    <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/it\/iniziative\/\" \n                                            aria-label=\"\" \n                                            target=\"_self\"\n                                        >\n                                            Scopri di pi\u00f9                                        <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/12065747\/Group-252.png')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/03\/13092135\/Module-5Environment_Gen-Ipsen-Environment-1.jpg\" alt=\"IMPEGNO SOCIALE\" title=\"IMPEGNO SOCIALE\">\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                                <span class=\"dash\"><\/span>\n                                <p class=\"heading-para\">\n                                    IMPEGNO SOCIALE                                <\/p>\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                            Disegniamo un futuro pi\u00f9 sostenibile                        <\/p>\n                        <p>Vogliamo proteggere e salvaguardare il nostro pianeta. La &#8220;Generation Ipsen ESG Responsibility Strategy&#8221; guida il nostro impegno per generare un cambiamento positivo in quattro aree chiave: Ambiente, Pazienti, Societ\u00e0 e Governance.<\/p>\n                            <a \n                            aria-label=\"\"  \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/it\/la-nostra-responsabilita\/\" \n                                target=\"_self\"\n                            > \n                                Scopri di pi\u00f9 \n                            <\/a>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n    <section class=\"title-text img-bg\">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2024\/05\/22060256\/Module-Careers_Banner-Home_1410x446pix.jpg)\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <h2 class=\"heading-three\">\n                            Lavorare in Ipsen                        <\/h2>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h3 class=\"heading-three\">\n                                                    <\/h3>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>Siamo una realt\u00e0 in continua evoluzione che vuole fare la differenza. Siamo impegnati a garantire un ambiente di lavoro stimolante e inclusivo, con molteplici opportunit\u00e0 di sviluppo professionale in diversi ambiti, da quello medico e di ricerca clinica, al marketing e commerciale, dal finance all\u2019HR, dalla comunicazione ai servizi legali.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                                        <div class=\"btn-txt\">\n                            <a \n                                aria-label=\"\" \n                                class=\"btn-link section-btn cta-visible\"  \n                                role=\"link\"\n                                href=\"https:\/\/ipsen.wd3.myworkdayjobs.com\/Ipsen_Careers\" target=\"_self\">\n                                Scopri le posizioni aperte                             <\/a>\n                        <\/div>\n                \n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo<\/title>\n<meta name=\"description\" content=\"Siamo un&#039;azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/it\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo\" \/>\n<meta property=\"og:description\" content=\"Siamo un&#039;azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/it\/\" \/>\n<meta property=\"og:site_name\" content=\"Italy\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-12T17:10:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/it\/\",\"url\":\"https:\/\/www.ipsen.com\/it\/\",\"name\":\"Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/it\/#website\"},\"datePublished\":\"2023-12-22T11:00:28+00:00\",\"dateModified\":\"2025-02-12T17:10:24+00:00\",\"description\":\"Siamo un'azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/it\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/it\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/it\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/it\/#website\",\"url\":\"https:\/\/www.ipsen.com\/it\/\",\"name\":\"Italy\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/it\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/it\/#organization\",\"name\":\"Italy\",\"url\":\"https:\/\/www.ipsen.com\/it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.ipsen.com\/it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2023\/12\/22131926\/Logo-Ipsen.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2023\/12\/22131926\/Logo-Ipsen.svg\",\"caption\":\"Italy\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/it\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo","description":"Siamo un'azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/it\/","og_locale":"it_IT","og_type":"article","og_title":"Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo","og_description":"Siamo un'azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.","og_url":"https:\/\/www.ipsen.com\/it\/","og_site_name":"Italy","article_modified_time":"2025-02-12T17:10:24+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/it\/","url":"https:\/\/www.ipsen.com\/it\/","name":"Ipsen \u2013 risposte innovative per i pazienti di tutto il mondo","isPartOf":{"@id":"https:\/\/www.ipsen.com\/it\/#website"},"datePublished":"2023-12-22T11:00:28+00:00","dateModified":"2025-02-12T17:10:24+00:00","description":"Siamo un'azienda biofarmaceutica globale con una grande ambizione: offrire soluzioni terapeutiche in oncologia, neuroscienze e malattie rare.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/it\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/it\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/it\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/it\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/it\/#website","url":"https:\/\/www.ipsen.com\/it\/","name":"Italy","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/it\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/it\/#organization","name":"Italy","url":"https:\/\/www.ipsen.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.ipsen.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2023\/12\/22131926\/Logo-Ipsen.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/9\/2023\/12\/22131926\/Logo-Ipsen.svg","caption":"Italy"},"image":{"@id":"https:\/\/www.ipsen.com\/it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/pages\/6","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/comments?post=6"}],"version-history":[{"count":35,"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/pages\/6\/revisions"}],"predecessor-version":[{"id":39687,"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/pages\/6\/revisions\/39687"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/it\/wp-json\/wp\/v2\/media?parent=6"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}